☆Casdin Capital, LLC
Quality Q
0.818
AUM ($M)
1,998
Positions
43
Turnover
0.16
Top-10 wt
77%
Herfindahl
0.110
History (qtrs)
6
Excess Return
+14.4%
AI Eval Run AI Eval
Holdings · 46 positions · portfolio value $1,998M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆RVMD funds › | REVOLUTION MEDICINES INC | HOLD | — | 24.2% | +5.2% | 482.7 | 2,577,333 | +0 | 5 | — |
| ☆RLAY funds › | RELAY THERAPEUTICS INC | ADD | — | 15.0% | +4.2% | 300.0 | 16,035,240 | +1,616,666 | 5 | — |
| ☆WGS funds › | GENEDX HOLDINGS CORP | ADD | — | 12.7% | -1.9% | 254.5 | 3,707,164 | +700,000 | 5 | — |
| ☆BLFS funds › | BIOLIFE SOLUTIONS INC | TRIM | — | 6.6% | -2.0% | 131.5 | 4,655,000 | -1,302,165 | 5 | — |
| ☆ILMN funds › | ILLUMINA INC | HOLD | — | 4.7% | -0.3% | 93.2 | 530,000 | +0 | 5 | — |
| ☆LAB funds › | STANDARD BIOTOOLS INC | HOLD | — | 3.7% | -2.5% | 73.0 | 88,783,856 | +0 | 5 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | HOLD | — | 3.2% | -1.1% | 63.1 | 1,175,000 | +0 | 5 | — |
| ☆DNLI funds › | DENALI THERAPEUTICS INC | ADD | — | 2.6% | -0.0% | 52.6 | 2,045,000 | +205,000 | 5 | — |
| ☆NGNE funds › | NEUROGENE INC | ADD | — | 2.4% | +0.3% | 48.6 | 1,545,361 | +125,000 | 5 | — |
| ☆BEAM funds › | BEAM THERAPEUTICS INC | HOLD | — | 2.3% | -0.1% | 46.3 | 1,350,000 | +0 | 5 | — |
| ☆TXG funds › | 10X GENOMICS INC | TRIM | — | 2.0% | -1.6% | 40.3 | 1,050,000 | -1,225,000 | 3 | +435.3% |
| ☆SRRK funds › | SCHOLAR ROCK HLDG CORP | ADD | — | 1.8% | +0.5% | 36.6 | 665,000 | +315,000 | 3 | +39.3% |
| ☆PSNL funds › | PERSONALIS INC | ADD | — | 1.7% | +0.9% | 34.2 | 2,550,000 | +950,000 | 2 | +143.8% |
| ☆GRAL funds › | GRAIL INC | ADD | — | 1.6% | +0.7% | 32.8 | 480,000 | +250,000 | 2 | -85.5% |
| ☆GH funds › | GUARDANT HEALTH INC | TRIM | — | 1.4% | -0.8% | 27.8 | 185,000 | -130,000 | 5 | — |
| ☆MAZE funds › | MAZE THERAPEUTICS INC | ADD | — | 1.3% | -0.5% | 25.2 | 843,857 | +85,000 | 5 | — |
| ☆HIMS funds › | HIMS & HERS HEALTH INC | HOLD | — | 1.2% | +0.1% | 24.3 | 700,000 | +0 | 5 | — |
| ☆ALNY funds › | ALNYLAM PHARMACEUTICALS INC | HOLD | — | 1.1% | -0.7% | 22.6 | 75,000 | +0 | 5 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | HOLD | — | 1.1% | +0.0% | 22.1 | 3,250,000 | +0 | 3 | +39.9% |
| ☆AGMB funds › | AGOMAB THERAPEUTICS NV | HOLD | — | 1.0% | -0.2% | 20.1 | 1,550,000 | +0 | 2 | -55.9% |
| ☆SEPN funds › | SEPTERNA INC | HOLD | — | 0.9% | -0.1% | 18.5 | 553,268 | +0 | 5 | — |
| ☆PBLS funds › | PARABILIS MEDICINES INC | NEW | — | 0.9% | +0.9% | 17.7 | 645,690 | +645,690 | 1 | +111.1% |
| ☆SION funds › | SIONNA THERAPEUTICS INC | NEW | — | 0.9% | +0.9% | 17.6 | 400,000 | +400,000 | 1 | -124.2% |
| ☆VCYT funds › | VERACYTE INC | HOLD | — | 0.8% | +0.1% | 16.2 | 276,308 | +0 | 5 | — |
| ☆ANL funds › | ADLAI NORTYE LTD | ADD | — | 0.7% | +0.4% | 14.4 | 1,250,000 | +711,539 | 2 | +61.3% |
| ☆PRME funds › | PRIME MEDICINE INC | HOLD | — | 0.6% | -0.2% | 11.7 | 3,167,175 | +0 | 5 | — |
| ☆ABSI funds › | ABSCI CORPORATION | HOLD | Common Stock | 0.6% | +0.3% | 11.3 | 973,260 | +0 | 5 | — |
| ☆DGX funds › | QUEST DIAGNOSTICS INC | HOLD | — | 0.5% | -0.2% | 10.6 | 50,000 | +0 | 3 | +14.5% |
| ☆SRPT funds › | SAREPTA THERAPEUTICS INC | NEW | — | 0.4% | +0.4% | 8.4 | 470,000 | +470,000 | 1 | +5.1% re-entry |
| ☆QURE funds › | UNIQURE NV | NEW | — | 0.3% | +0.3% | 6.9 | 150,000 | +150,000 | 1 | +1475.5% |
| ☆NTLA funds › | INTELLIA THERAPEUTICS INC | HOLD | — | 0.3% | -0.0% | 6.0 | 355,000 | +0 | 2 | -36.7% |
| ☆MRNA funds › | MODERNA INC | HOLD | — | 0.3% | -0.0% | 5.3 | 75,000 | +0 | 2 | +80.2% |
| ☆IRON funds › | DISC MEDICINE INC | HOLD | — | 0.2% | -0.1% | 4.8 | 65,000 | +0 | 2 | +14.4% |
| ☆GLUE funds › | MONTE ROSA THERAPEUTICS INC | HOLD | — | 0.2% | -0.0% | 4.5 | 186,014 | +0 | 5 | — |
| ☆IPSC funds › | CENTURY THERAPEUTICS INC | HOLD | — | 0.2% | -0.1% | 3.0 | 1,228,190 | +0 | 5 | — |
| ☆CTNM funds › | CONTINEUM THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 2.4 | 148,333 | +0 | 5 | — |
| ☆BBOT funds › | BRIDGEBIO ONCOLOGY THERAPEUT | HOLD | — | 0.1% | -0.1% | 2.2 | 282,312 | +0 | 4 | -37.1% |
| ☆EDIT funds › | EDITAS MEDICINE INC | NEW | — | 0.1% | +0.1% | 1.4 | 445,000 | +445,000 | 1 | +32.6% |
| ☆PACB funds › | PACIFIC BIOSCIENCES CALIF IN | HOLD | — | 0.1% | -0.0% | 1.2 | 723,767 | +0 | 5 | — |
| ☆KARD funds › | KARDIGAN INC | NEW | — | 0.1% | +0.1% | 1.2 | 50,000 | +50,000 | 1 | -82.0% |
| ☆RXRX funds › | RECURSION PHARMACEUTICALS IN | HOLD | — | 0.0% | -0.0% | 0.6 | 165,323 | +0 | 5 | — |
| ☆DNA funds › | GINKGO BIOWORKS HOLDINGS INC | HOLD | — | 0.0% | +0.0% | 0.4 | 36,493 | +0 | 5 | — |
| ☆TNYA funds › | TENAYA THERAPEUTICS INC | HOLD | — | 0.0% | -0.0% | 0.3 | 361,969 | +0 | 5 | — |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -450,000 | 0 | -61.8% |
| ☆TEM funds › | TEMPUS AI INC | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -294,127 | 0 | -71.5% |
| ☆QGEN funds › | QIAGEN NV | EXIT | — | 0.0% | -1.1% | 0.0 | 0 | -360,000 | 0 | -116.5% |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,998 | 43 | 0.16 | 77% | 0.110 | 0.816 | — | in |
| 2026Q1 | 1,321 | 40 | 0.22 | 77% | 0.090 | 0.680 | — | in |
| 2025Q4 | 1,610 | 38 | 0.15 | 79% | 0.104 | 0.788 | — | in |
| 2025Q3 | 1,199 | 32 | 0.14 | 85% | 0.124 | 0.812 | — | in |
| 2025Q2 | 1,098 | 33 | 0.15 | 85% | 0.137 | 0.816 | — | entered |
| 2025Q1 | 1,224 | 44 | 0.00 | 80% | 0.117 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status